Citadel Advisors’s Fennec Pharmaceuticals FENC Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $388K | Buy |
+46,783
| New | +$388K | ﹤0.01% | 4331 |
|
|
2024
Q2 | – | Sell |
-48,714
| Closed | -$542K | – | 6183 |
|
|
2024
Q1 | $542K | Buy |
+48,714
| New | +$542K | ﹤0.01% | 3812 |
|
|
2023
Q4 | – | Sell |
-13,710
| Closed | -$103K | – | 6125 |
|
|
2023
Q3 | $103K | Sell |
13,710
-25,616
| -65% | -$192K | ﹤0.01% | 4829 |
|
|
2023
Q2 | $347K | Buy |
39,326
+4,056
| +11% | +$35.8K | ﹤0.01% | 3971 |
|
|
2023
Q1 | $293K | Buy |
35,270
+7,216
| +26% | +$60K | ﹤0.01% | 4315 |
|
|
2022
Q4 | $269K | Buy |
28,054
+12,378
| +79% | +$119K | ﹤0.01% | 4433 |
|
|
2022
Q3 | $127K | Buy |
+15,676
| New | +$127K | ﹤0.01% | 5027 |
|
|
2022
Q1 | – | Sell |
-14,874
| Closed | -$65K | – | 6587 |
|
|
2021
Q4 | $65K | Buy |
+14,874
| New | +$65K | ﹤0.01% | 6080 |
|
|
2021
Q3 | – | Hold |
0
| – | – | – | 6577 |
|
|
2021
Q2 | – | Hold |
0
| – | – | – | 6594 |
|
|
2020
Q4 | – | Hold |
0
| – | – | – | 5210 |
|
|
2020
Q3 | – | Hold |
0
| – | – | – | 4835 |
|
|
2020
Q2 | – | Hold |
0
| – | – | – | 4841 |
|
|
2020
Q1 | – | Hold |
0
| – | – | – | 4981 |
|